Dec. 02, 2009 - Issue #737: Climate Crossroads
Well, Well, Well
THE MEDICAL INDUSTRY
The truth is out there: Hard to find all the facts with pharmaceuticals
A conversation with a friend last weekend about pharmaceutical giant
Pfizer's unethical behaviour threw me a little. The company recently paid a
$1.19 billion criminal fine, and $1 billion to settle civil cases around its
promotion of Bextra and other drugs for off-label use. Is my view of the
elephant a naïve and simplistic one, or does harm being done by the
industry in fact at times outweigh the good? It is after all, as I'm often
reminded, true that orthodox medical wisdom comes to us from some of the best
minds in the world, and it could well be argued that it is hubris on my part
to be as skeptical as I am.
I considered all this, as I'm prone to do, overnight, subconsciously. I awoke
the next morning clear again—it's not that I'm presuming to know more
than all these brilliant scientists do; it is simply that I have a view from
a distance. This view is clear: whatever the miracles of medical science,
we're medicating more than ever before in human history. We're living longer,
but not better. It has become difficult to find a child without asthma or
ADHD or anxiety. I am an anomaly among my 50-something peers in that, almost
without fail, they need to use pharmaceuticals to sleep, to keep their bones
strong, to keep cholesterol normal, to keep arthritis pain and anxiety and
hot flashes and fatigue at bay.
The view from a distance has convinced me that medical science, as a giant
industry, desperately needs a critical and watchful eye on it, and that the
recommendations originating in the industry and being passed on through
Health Canada and the doctors caring for us deserve only carefully chosen
acceptance. No matter how hard-working and brilliant the minds behind
orthodox wisdom, it has historically often missed the forest for the trees,
and led us astray.
My view from a distance also permits me to measure medical advice against the
backdrop of the mostly-untold stories—those of the scientists once on
the inside of the research establishment or Health Canada and now exiled, the
facts about immense gaps between the science and medical practice and the
personal stories of those injured on conventional wisdom and mostly blacked
out by the media. It permits me to measure medical advice against the big
picture—prescription drugs, used properly and according to approved
uses, kill tens of thousands of us each year, and seriously injure several
million. Iatrogenic disease is a leading cause of death in the developed
world.
Orthodox medical wisdom should also be measured in light of how the
competitive peer review publication and research grant process works. Access
to funding depends on peer review, giving scientists much power over the
careers of their competitors. Despite the goals and strengths of a peer
review system, its drawbacks are obvious: were we to put competitors in
charge of approving new and at times unprofitable ideas in other markets,
innovation would slow dramatically and precious few major shifts of
improvement would reach the public.
The incontrovertible fact is that most of those willing to go against the
flow of research are those who are not dependent on the system for funding;
they are also the ones who will have great difficulty publishing their
findings.
Again, I'm not saying we need no pharmaceuticals—we clearly do, most
especially now that we've become as chronically ill as we have. They can save
lives, and make it bearable. We need relief.
My point is simply that we can get bogged down in discussions of off-label
use of drugs and unethical behaviour, and whether or not it is advisable to
deliver a potentially fatal blow to the industry, but we need a much bigger
shift of focus. All drug use—both approved and off-label—should
happen only with full risk disclosure, and full risk disclosure happens far
too rarely. That's the biggest issue, the fact that drug information comes
primarily from an industry which understandably has motivation to overstate
the benefits and downplay the risks of its products. The biggest issue is the
fact that medical science itself has become a big industry.
It's a worn groove by now, I know, but we might actually see something very
positive come out of changing course a little as a whole, taking a wider
berth around the drug-for-everything iceberg. It's not like it's working all
that well or anything, and we might actually see a decline in our ravenous
hunger for relief. V
More stories in front »
New comments for this entry have been turned off and any existing ones are hidden. We apologize for any inconvenience.
